Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Anthrax action shapes up

24.10.2001


Anthrax is under close scrutiny.
© AP/Fort Detrick, US Army


Washington’s Dirkin Senate Office gets a careful clean-up.
© AP/Kenneth Lambert


Researchers find two new leads for anti-anthrax drugs.

As fears over bioterrorism attacks spiral, researchers are making progress towards better anthrax drugs - but these are unlikely to reach the drugstore soon.

Of ten confirmed anthrax cases in the United States by Monday, four have been of the severe, inhaled form against which antibiotics often fail. By the time drugs destroy the bacteria responsible, Bacillus anthracis, the organisms have released enough lethal toxin to kill immune cells in the blood, causing fatal blood poisoning.



Two new discoveries lay the groundwork for drugs that could disable the toxin and, along with antibiotics, save lives.

John Young, of the University of Wisconsin in Madison, and his colleagues have pinpointed the protein, on the surface of human cells, which the anthrax toxin latches onto1. In the lab a synthetic version of this ’receptor’ mops up the poison and protects cells. "It serves as a decoy," Young explains.

Part of the toxin attaches to this receptor, punches a hole in the human cell membrane and injects another part, the ’lethal factor’, which destroys proteins in the cell. A second team, led by Robert Liddington of The Burnham Institute in La Jolla, California, have deduced the structure of this lethal factor2.

With a picture of how the toxin’s proteins attack cells, drug companies can search for chemicals that block their activity, the teams hope.

This promise is unlikely to be realized in time to help the current situation, Young and Liddington caution - most optimistic estimates are that improvements will be a year in the making. "We need to design drugs - not for this time round but for the next one," says Liddington.

Alternative medicine

The current crisis gives the hunt for effective treatments new urgency. What we have is no longer "state-of-the-art", says Richard Corlin, director of the American Medical Association in Chicago, Illinois. The latest work "will lead us to a better treatment", he agrees.

Excessive use of an existing antibiotic, ciprofloxacin, could create its own medical problems, Corlin warns. The drug destroys healthy bacteria in the body, so may leave people open to infection from other pathogens.

Overuse of antibiotics and failure to complete the 60-day course virtually "guarantee the emergence of antibiotic resistant strains" of these pathogenic bacteria, he says, making such infections difficult to treat.

Bioterrorists could potentially engineer antibiotic-resistant anthrax. Manufacturing bacteria able to withstand toxin-targeted drugs would be "almost impossible", says John Collier of Harvard Medical School, who contributed to both studies. It would require expert biochemical knowledge to alter specific protein shapes and interactions.

The anthrax vaccine is also problematic. Developed in the 1960s, it involves injecting a crude mix of the toxin’s protein components to stimulate resistance. Vaccination requires six shots and regular boosters. The vaccine is currently produced only in sufficient quantities for the US military.

Several groups are designing more effective versions using purified proteins, explains anthrax researcher Stephen Leppla of the National Institute of Dental and Craniofacial Reseach in Bethesda, Maryland. These are easily administered and produce long-lasting immunity. "Before too long, we’ll have it," he predicts.

Ultimately, we need a whole new arsenal to fight anthrax, says Collier - a new antibiotic, a safe, efficient vaccine, and drugs against toxins. Realizing this goal requires further funding for research and fast-track approval of candidate drugs, he suggests.

Meanwhile most people agree that heightened awareness remains the best form of defence, catching early, cold-like symptoms in time for the disease to be treated. "The key thing is an appropriate degree of surveillance," says Corbin.

Spore show

Anthrax spores, the persistent, dormant form of the bacterium, can cause infection through the skin and intestine, but inhalation is the most dangerous - around 90% of cases result in death.

Turning anthrax into an effective bioweapon is technically difficult - spores must be milled down into a very fine powder (less than 5 micrometres in diameter) for them to reach the depths of the lungs in sufficient quantities to cause infection. A dose of around 10,000 spores is thought to cause a lethal infection.

Spores sent in letters to media and political organizations in the United States had produced ten confirmed cases by the end of Monday, including one death. The deaths of two more postal workers have been linked to the disease. The source of the letters has not yet been found, and the United States is offering a $1-million reward for information leading to the identification of those responsible.

References
  1. Bradley, K.A., Mogridge, J., Mourez, M., Collier, R.J. & Young, J.A.T. Identification of the cellular receptor for the anthrax toxin. Nature, (2001).

  2. Panniter, A. et al. Crystal structure of the anthrax lethal factor. Nature, (2001).


HELEN PEARSON | Nature News Service
Further information:
http://www.nature.com/nsu/011025/011025-9.html
http://www.nature.com/nsu/

More articles from Health and Medicine:

nachricht One gene closer to regenerative therapy for muscular disorders
01.06.2017 | Cincinnati Children's Hospital Medical Center

nachricht The gut microbiota plays a key role in treatment with classic diabetes medication
01.06.2017 | University of Gothenburg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Quantum thermometer or optical refrigerator?

23.06.2017 | Physics and Astronomy

A 100-year-old physics problem has been solved at EPFL

23.06.2017 | Physics and Astronomy

Equipping form with function

23.06.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>